Versant Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$77.7K Buy
1,413
+1,245
+741% +$68.4K 0.01% 779
2025
Q1
$11.9K Sell
168
-144
-46% -$10.2K ﹤0.01% 1635
2024
Q4
$20.5K Buy
312
+227
+267% +$14.9K ﹤0.01% 1025
2024
Q3
$5.98K Sell
85
-16
-16% -$1.13K ﹤0.01% 1235
2024
Q2
$8.32K Buy
101
+87
+621% +$7.16K ﹤0.01% 1049
2024
Q1
$1.22K Sell
14
-9
-39% -$786 ﹤0.01% 1489
2023
Q4
$2.22K Buy
23
+6
+35% +$579 ﹤0.01% 1256
2023
Q3
$1.5K Sell
17
-9
-35% -$796 ﹤0.01% 1407
2023
Q2
$2.25K Buy
26
+12
+86% +$1.04K ﹤0.01% 1333
2023
Q1
$1.36K Hold
14
﹤0.01% 1367
2022
Q4
$1.45K Hold
14
﹤0.01% 1216
2022
Q3
$1K Hold
14
﹤0.01% 1191
2022
Q2
$1K Buy
14
+3
+27% +$214 ﹤0.01% 1209
2022
Q1
$1K Hold
11
﹤0.01% 1236
2021
Q4
$1K Hold
11
﹤0.01% 1231
2021
Q3
$1K Sell
11
-4
-27% -$364 ﹤0.01% 1227
2021
Q2
$1K Buy
15
+4
+36% +$267 ﹤0.01% 1237
2021
Q1
$1K Hold
11
﹤0.01% 1320
2020
Q4
$0 Sell
11
-4
-27% ﹤0.01% 1342
2020
Q3
$1K Hold
15
﹤0.01% 1143
2020
Q2
$1K Hold
15
﹤0.01% 1139
2020
Q1
$1K Sell
15
-3
-17% -$200 ﹤0.01% 1103
2019
Q4
$1K Sell
18
-15
-45% -$833 ﹤0.01% 1209
2019
Q3
$2K Sell
33
-36
-52% -$2.18K ﹤0.01% 1141
2019
Q2
$5K Sell
69
-15
-18% -$1.09K ﹤0.01% 945
2019
Q1
$7K Sell
84
-5
-6% -$417 ﹤0.01% 1004
2018
Q4
$7K Hold
89
﹤0.01% 908
2018
Q3
$8K Hold
89
﹤0.01% 946
2018
Q2
$8K Hold
89
﹤0.01% 945
2018
Q1
$7K Hold
89
﹤0.01% 972
2017
Q4
$7K Hold
89
﹤0.01% 1008
2017
Q3
$8K Sell
89
-3
-3% -$270 ﹤0.01% 917
2017
Q2
$8K Hold
92
﹤0.01% 919
2017
Q1
$8K Sell
92
-35
-28% -$3.04K ﹤0.01% 904
2016
Q4
$10K Sell
127
-14
-10% -$1.1K 0.01% 812
2016
Q3
$13K Hold
141
0.01% 708
2016
Q2
$10K Sell
141
-7
-5% -$496 0.01% 773
2016
Q1
$12K Buy
148
+18
+14% +$1.46K 0.01% 690
2015
Q4
$13K Buy
+130
New +$13K 0.01% 645